This Week In The Bmj
Interferon alfa plus ribavirin combination therapy benefits patients with chronic hepatitis CBMJ 2001; 323 doi: http://dx.doi.org/10.1136/bmj.323.7322.0 (Published 17 November 2001) Cite this as: BMJ 2001;323:0
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial